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Supplementary Methods  
 
Unknown gene analysis  
First, a BED file was generated containing the novel gene models that were pairwise 
reproducible in at least one of the ENCODE tier 1 human cell lines. A second BED file 
of known genes was created from the GENCODE v29 annotation. Alu and LINE1 repeat 
files for the human genome (Dec. 2013 GRCh38/hg38) were downloaded in the BED 
format from the UCSC genome table browser. Data processing was performed using a 
custom bash script (available on GitHub). The Bedtools Intersect and Bedtools Closest 
commands were used to compare the unknown genes to the known ones, ascertaining 
whether they directly overlapped a known gene, or were located immediately 
upstream/downstream. The unknown genes were also intersected with the Alu and 
LINE1 repeats. In cases where an unknown gene fit into more than one subcategory of 
novelty, we prioritized overlaps with known genes.  
  
Epstein-Barr Virus transcriptome analysis  
An EBV chromosome GTF annotation was obtained from 
https://ebv.wistar.upenn.edu/downloadstatic/ebv.custom.gtf and refined for use. PacBio 
GM12878 reads that mapped to the EBV chromosome from the hg38 genome build 
were isolated and run through TranscriptClean using splice junctions generated from 
the GTF, and subsequently run through TALON. Gene and transcript TPMs were 
calculated using previously discussed filtering methodologies. CAGE and computational 
PAS support for novel transcripts was determined using previously discussed methods.  
 
PacBio read depth analysis 
The four PacBio GM12878 biological replicates were processed together using the 
TALON pipeline as described in the Methods section. ENCODE short reads from 
GM12878 were quantified using Kallisto and filtered as described in Methods. Short-
read genes were defined as those that were reproducibly detected in both Illumina 
replicates. Using a custom R script, we determined which of these short-read genes 
were detected in each PacBio replicate. Then, we permuted the PacBio datasets into all 
possible orderings and plotted the cumulative number of genes detected with increasing 
read count. 
 
Next, we compared the GC content of short-read genes also detected in PacBio to 
those that were not detected using a custom Python script. Fasta sequences for all 
known transcripts of each gene were obtained from the GENCODE v29 CHR transcript 
sequences file. The percent GC content of each transcript was computed from the 
sequence by summing the total number of G and C nucleotides and dividing by the 
transcript length.  
  
 
Supplementary Figure Legends 
Figure S1. TALON read length distributions for PacBio ENCODE Tier 1 datasets. a) 
GM12878 Rep 1. b) GM12878 Rep 2. c) K562 Rep 1. d) K562 Rep 2. e) HepG2 Rep 1. f) HepG2 
Rep 2. 
 
Figure S2. Characterization of unknown genes detected by PacBio in ENCODE tier 1 cell 
lines. a) Fraction of unknown genes belonging to various subcategories of novelty.  b) UCSC 
genome browser visualization of a novel gene that was reproducibly detected in GM12878, K562, 
and HepG2.  
 
Figure S3. PacBio gene expression in K562 and HepG2. a-b) Expression level of known genes 
in each biological replicate of a) HepG2 (Pearson r = 0.92), and b) K562 (Pearson r = 0.92). c-d) 
Proportion of genes expressed in Illumina RNA-seq data of c) HepG2 and d) K562 that are also 
detected in the corresponding PacBio data, binned by Illumina expression level (TPM).  
 
Figure S4. Further characterization of gene detection in GM12878 by short reads and 
PacBio long reads. a) Length of known genes binned by short-read expression level in GM12878 
and colored by PacBio detection status. Gene length was computed by taking the median length 
of all known transcripts per gene. b) Detection of known genes as a function of PacBio read depth 
in GM12878. The number of short-read genes that were detected in PacBio is shown cumulatively 
for each possible ordering of four PacBio datasets. c) GC content of known genes that were 
detected in at least one of four PacBio replicates, versus those that were detected in short reads 
only.  
 
  
Figure S5. Comparison of known gene expression levels across the PacBio and Illumina 
RNA-seq platforms. a) HepG2, and b) K562.  
 
Figure S6. Number of distinct transcript isoforms observed per novelty category in PacBio 
datasets. a) HepG2, and b) K562. 
 
Figure S7. PacBio transcript expression in K562 and HepG2. a-b) Expression level of known 
transcript models in each biological replicate of a) HepG2 (Pearson r = 0.86) and b) K562 
(Pearson r = 0.86). c-d) Expression of transcript models in each biological replicate of c) HepG2 
(Pearson r = 0.85) and d) K562 (Pearson r = 0.85), labeled by their novelty assignments. e-f) 
Comparison of known transcript expression levels across the PacBio and Illumina RNA-seq 
platforms in e) HepG2 and f) K562. g-h) Log2 of the total number of PacBio reads assigned to 
each novelty category after transcript filtering in g) HepG2 rep 1 and h) K562 rep 1.  
Figure S8. Number of exons per transcript model detected in PacBio ENCODE tier 1 cell 
line transcriptomes. Transcripts are grouped by novelty type assignment. 
 
Figure S9. Epstein-Barr Virus transcriptome characterization in GM12878. a) Gene 
expression levels in GM12878 from the EBV chromosome and from the human chromosomes, 
labelled by gene novelty. b) Transcript expression levels in GM12878 from the EBV chromosome 
and from the human chromosomes, labelled by transcript novelty. Novel transcripts have been 
filtered for reproducibility between GM12878 biological replicates. c) Visualization of TALON GTF 
annotations in the UCSC genome browser for EBV transcripts in GM12878. 
 
Figure S10. TALON read length distributions for Nanopore ENCODE Tier 1 cell line 
datasets. a) GM12878 Rep 1. b) GM12878 Rep 2. c) GM12878 Rep 3. d) K562 Rep 1. e) K562 
Rep 2. f) HepG2 Rep 1. g) HepG2 Rep 2. h) HepG2 Rep 3. 
  
 
Figure S11. Characterization of ENCODE tier 1 cell lines by Oxford Nanopore direct-RNA 
sequencing. a) Expression level of known transcript models and reproducible ISMs in PacBio vs. 
ONT for GM12878 (Pearson r = 0.21). b-c) Expression levels of known genes in two biological 
replicates of b) HepG2 (Pearson r = 0.84) and c) K562 (Pearson r = 0.73). d-e) Expression level 
of known GENCODE v29 transcript models and reproducible ISMs in two ONT biological 
replicates of d) HepG2 (Pearson r = 0.60) and e) K562 (Pearson r = 0.51).  
 
Figure S12. Comparison of ONT and PacBio platforms in HepG2 and K562. a-b) Expression 
levels of known genes and reproducible antisense genes in PacBio vs. ONT for a) HepG2 
(Pearson r = 0.75) and b) K562 (Pearson r = 0.75). c-d) Expression level of known transcript 
models and reproducible ISMs in PacBio vs. ONT for c) HepG2 (Pearson 0.27) and d) K562 
(Pearson r = 0.34).  
 
Figure S13. PacBio and ONT GM12878 post-TranscriptClean reads mapping to the XRCC5 
locus. 
 
Figure S14. CAGE support by novelty category in HepG2 and K562. a-d) Percentage of 
TALON transcript models with CAGE support for their 5’ end by novelty category in a) HepG2 
PacBio, b) K562 PacBio, c) HepG2 ONT, and d) K562 ONT.  
 
Figure S15. Poly(A) motif support by novelty category in HepG2 and K562. a-d) Percentage 
of TALON transcript models with a computationally predicted poly(A) motif within 35 nt of the 3’ 
end by novelty category in a) HepG2 PacBio, b) K562 PacBio, c) HepG2 ONT, and d) K562 ONT.  
 
  
Figure S16. RNA-PET support by novelty category in HepG2 and K562. a-d) Percentage of 
TALON transcript models with RNA-PET support for their 5’-3’ end pair by novelty category in a) 
HepG2 PacBio, b) K562 PacBio, c) HepG2 ONT, and d) K562 ONT.  
 
Figure S17. 5’ and 3’ end completeness of PacBio Epstein-Barr Virus transcripts. a) 
Percentage of TALON EBV transcript models with CAGE support for their 5’ end by novelty 
category. b) Percentage of TALON EBV transcript models with a computationally predicted 
poly(A) motif within 35 nt of the 3’ end by novelty category. 
 
Figure S18. Reproducibility of PacBio gene and transcript expression in mouse cortex and 
hippocampus. a) Expression level of known genes in each cortex biological replicate. b) 
Expression level of known transcripts in each cortex biological replicate. c) Expression level of 
known genes in each hippocampus biological replicate. d) Expression level of known transcripts 
in each hippocampus biological replicate.   
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--- 
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RNA 
K562 2 ---  
GSM3891592 
604,000  
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